Schnellzugriff

No journals followed

Browse journals

No saved papers

Feed Entdecken shellTopNav.journalClub Trends Fragen Forschende

⌘K

Prevalence and Clinical Course of Methemoglobinemia After Cardiac Device Implantation. | Synapse

April 10, 2026

Prevalence and Clinical Course of Methemoglobinemia After Cardiac Device Implantation.

Key Points

This research aims to investigate the prevalence of methemoglobinemia after cardiac device implantations and its clinical implications.
Conducted an observational study on patients receiving cardiac implantable electronic devices (CIEDs).
Monitored methemoglobin levels post-implantation.
Established practical thresholds for early recognition, specifically >3% FMetHb.
Found that methemoglobinemia occurs more frequently than previously thought after CIED implantation.
Early recognition and management of levels above 3% FMetHb led to improved clinical outcomes.

Abstract

Methemoglobinemia may occur more frequently than expected following CIED implantation and early recognition and stratification using practical thresholds such as >3% FMetHb support timely management and improved outcomes.

Connected Papers

Building similarity graph...

Analyzing shared references across papers

Discussion

Loading...

Authors

A

Ahmet Lütfü Sertdemir

A

Ahmet Taha Şahin

H

Hasan Kan

Actions

Institutions

Necmettin Erbakan University

References and Citations

Connected Papers

Building similarity graph...

Analyzing shared references across papers

Discussion

Loading...

Cite this study

Sertdemir et al. (Fri,) studied this question.

www.synapsesocial.com/papers/69d893626c1944d70ce0461b — DOI: https://doi.org/10.5543/tkda.2026.19946